Cargando…

Coagulofibrinolytic effects of recombinant soluble thrombomodulin in prolonged porcine cardiac arrest

AIM: To evaluate coagulofibrinolytic abnormalities and the effects of ART-123 (recombinant human thrombomodulin alpha) in a porcine model of cardiac arrest and prolonged cardiopulmonary resuscitation (CA/CPR). METHODS: Fifteen pigs (n = 5 per group) underwent 8 minutes of no-flow CA followed by 50 m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Boya, McCracken, Brendan M., Mahmood, Carmen Colmenero, Leander, Danielle, Greer, Nicholas, Cranford, James A., Hsu, Cindy H., Tiba, Mohamad Hakam, Neumar, Robert W., Greineder, Colin F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Experimental Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550843/ https://www.ncbi.nlm.nih.gov/pubmed/37811363 http://dx.doi.org/10.1016/j.resplu.2023.100477

Ejemplares similares

Therapeutic Effect of Argatroban During Cardiopulmonary Resuscitation and Streptokinase During Extracorporeal Cardiopulmonary Resuscitation in a Porcine Model of Prolonged Cardiac Arrest
por: VanZalen, Jensyn J., et al.
Publicado: (2023)

A review of two emerging technologies for pre‐hospital treatment of non‐compressible abdominal hemorrhage
por: McCracken, Brendan M., et al.
Publicado: (2022)

Coagulofibrinolytic Changes in Patients with Post-cardiac Arrest Syndrome
por: Wada, Takeshi
Publicado: (2017)

Aerosol generation during chest compression and defibrillation in a swine cardiac arrest model
por: Hsu, Cindy H., et al.
Publicado: (2021)

Dose optimization of early high-dose valproic acid for neuroprotection in a swine cardiac arrest model
por: Hsu, Cindy H., et al.
Publicado: (2020)

Association of Histones With Coagulofibrinolytic Responses and Organ Dysfunction in Adult Post-cardiac Arrest Syndrome
por: Mizugaki, Asumi, et al.
Publicado: (2022)

A comprehensive assessment of multi-system responses to a renal inoculation of uropathogenic E. coli in swine
por: Tiba, Mohamad Hakam, et al.
Publicado: (2020)

Efficacy of recombinant human soluble thrombomodulin in disseminated intravascular coagulation
por: Yasuda, T, et al.
Publicado: (2010)

Differences in coagulofibrinolytic changes between post‐cardiac arrest syndrome of cardiac causes and hypoxic insults: a pilot study
por: Wada, Takeshi, et al.
Publicado: (2017)

Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced DIC
por: Yamakawa, K, et al.
Publicado: (2014)

Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin
por: Katayama, Shinshu, et al.
Publicado: (2017)

Perioperative coagulofibrinolytic responses in colorectal surgery patients without chemical thromboprophylaxis: a retrospective observational study
por: Matsumoto, Hironori, et al.
Publicado: (2021)

Combination therapy with sivelestat and recombinant human soluble thrombomodulin for ARDS and DIC patients
por: Miyoshi, Seigo, et al.
Publicado: (2014)

Effects of probucol on atherosclerotic plaque and soluble thrombomodulin in patients with coronary heart disease
por: Liu, Donghai, et al.
Publicado: (2018)

Efficacy of Coagulofibrinolytic Markers for Postoperative Prediction of Venous Thromboembolism in Colorectal Surgery Patients: A Retrospective Observational Study
por: Matsumoto, Hironori, et al.
Publicado: (2023)

Clinical efficacy of recombinant human soluble thrombomodulin in patients with septic disseminated intravascular coagulation
por: Suzuki, Y, et al.
Publicado: (2013)

Therapeutic Role of Recombinant Human Soluble Thrombomodulin for Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Isshiki, Takuma, et al.
Publicado: (2019)

Plasma From Patients Undergoing Liver Transplantation Is Resistant to Anticoagulant Activity of Soluble Thrombomodulin
por: Burlage, Laura C., et al.
Publicado: (2019)

Association between arsenic exposure and soluble thrombomodulin: A cross sectional study in Bangladesh
por: Hasibuzzaman, M. M., et al.
Publicado: (2017)

Protective Effects of Recombinant Human Soluble Thrombomodulin on Lipopolysaccharide-Induced Acute Kidney Injury
por: Nozaki, Yuji, et al.
Publicado: (2020)

Enhanced effect of recombinant human soluble thrombomodulin by ultrasound irradiation in acute liver failure
por: Hoshino, Kota, et al.
Publicado: (2020)

Effects of tranexamic acid on coagulofibrinolytic markers during the early stage of severe trauma: A propensity score–matched analysis
por: Gando, Satoshi, et al.
Publicado: (2022)

Breath analysis for detection and trajectory monitoring of acute respiratory distress syndrome in swine
por: Sharma, Ruchi, et al.
Publicado: (2022)

The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study
por: Yoshihara, Masato, et al.
Publicado: (2015)

Clinical Impact of Recombinant Soluble Thrombomodulin for Disseminated Intravascular Coagulation Associated with Severe Acute Cholangitis
por: Okuda, Atsushi, et al.
Publicado: (2018)

Pharmacokinetics of Recombinant Human Soluble Thrombomodulin in Disseminated Intravascular Coagulation Patients with Acute Renal Dysfunction
por: Hayakawa, Mineji, et al.
Publicado: (2017)

Recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy (SCARLET): an updated meta-analysis
por: Yamakawa, Kazuma, et al.
Publicado: (2019)

Acute Portal Vein Thrombosis Treated with Recombinant Human Soluble Thrombomodulin Combined with Antithrombin III
por: Nakayama, Satoshi, et al.
Publicado: (2020)

Vascular Immunotargeting to Endothelial Determinant ICAM-1 Enables Optimal Partnering of Recombinant scFv-Thrombomodulin Fusion with Endogenous Cofactor
por: Greineder, Colin F., et al.
Publicado: (2013)

A novel swine model of the acute respiratory distress syndrome using clinically relevant injury exposures
por: Tiba, Mohamad H., et al.
Publicado: (2021)

Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model
por: Iba, Toshiaki, et al.
Publicado: (2009)

Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study
por: Yamakawa, Kazuma, et al.
Publicado: (2011)

Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia
por: Ookura, Miyuki, et al.
Publicado: (2018)

Circulating activated protein C levels are not increased in septic patients treated with recombinant human soluble thrombomodulin
por: Arishima, Takuro, et al.
Publicado: (2018)

Dynamics of Soluble Thrombomodulin and Circulating miRNAs in Patients with Atrial Fibrillation Undergoing Radiofrequency Catheter Ablation
por: Namino, Fuminori, et al.
Publicado: (2019)

Recombinant Human Soluble Thrombomodulin Suppresses Monocyte Adhesion by Reducing Lipopolysaccharide-Induced Endothelial Cellular Stiffening
por: Okamoto, Takayuki, et al.
Publicado: (2020)

Factors influencing the effectiveness of recombinant human soluble thrombomodulin on disseminated intravascular coagulation: a retrospective study
por: Asai, Yuki, et al.
Publicado: (2020)

Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: a nationwide observational study
por: Awano, Nobuyasu, et al.
Publicado: (2022)

Hypertonic saline maintains coagulofibrinolytic homeostasis following moderate-to-severe traumatic brain injury by regulating monocyte phenotype via expression of lncRNAs
por: Yang, Xiping, et al.
Publicado: (2019)

Gender-related differences in the coagulofibrinolytic responses and long-term outcomes in patients with isolated traumatic brain injury: A 2-center retrospective study
por: Tsuchida, Takumi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_flp6kffoid6b02it4nt4r47hed